Mindfulness program proves a secret weapon against post-traumatic stress

These fndings indicate that, while MBCT is a reliable and e

fcacious intervention,

there is a need to address the sustainability of treatment-related improvements in patients with

BD

new study examines the potential of artificial intelligence to shift chronic pain treatment from opioids to mindfulness-based stress reduction (MBSR). Utilizing machine learning to analyze extensive patient data, the study aims to predict which patients will benefit most from MBSR, a critical step towards personalized medicine.

In a Phase II trial of patients who suffered from chronic, treatment-resistant PTSD for an average of 17 years, 56% showed no signs of the condition after one MDMA-assisted therapy session. Following up at the one-year mark, 68% no longer had PTSD.